Skip to main content
. 2001 Nov;159(5):1895–1904. doi: 10.1016/S0002-9440(10)63036-2

Figure 4.

Figure 4.

Different kinetics of NF-κB and AP-1 activation between WT and AT1(−/−). Electrophoretic mobility shift assay showed that NF-κB activation in AT1(−/−) was significantly attenuated only at day 14 (at day 7: 2.6 ± 0.7-fold versus 2.7 ± 1.9-fold increase, n = 4, P = 0.97; at day 14: 2.2 ± 0.7 versus 5.2 ± 1.7, n = 4, *P < 0.05), whereas AP-1 activation was absent in AT1(−/−) during the disease outcome (at day 7: 1.3 ± 0.1 versus 2.4 ± 0.7, n = 4, *P < 0.05; at day 14: 1.3 ± 0.3 versus 2.2 ± 0.2, n = 4, **P < 0.01). Lane C denotes co-incubation with NF-κB or AP-1 cold oligos.